Omnicell traded at $109.11 this Friday August 12th, decreasing $0.07 or 0.06 percent since the previous trading session. Looking back, over the last four weeks, Omnicell lost 2.86 percent. Over the last 12 months, its price fell by 28.53 percent. Looking ahead, we forecast Omnicell to be priced at 106.10 by the end of this quarter and at 97.52 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
109.11
Daily Change
-0.06%
Yearly
-28.53%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AmerisourceBergen 148.94 0.72 0.49% 24.56%
Becton, Dickinson and Co. 260.95 1.55 0.60% 5.74%
HeartBeam 1.46 -0.09 -5.81% -68.87%
Benefitfocus 7.73 -0.09 -1.15% -34.10%
Cardinal Health 68.45 2.45 3.71% 32.40%
Computer Programs Systems 30.70 0.22 0.72% -11.58%
Healthcare Services 14.60 0.15 1.04% -45.81%
HealthStream 23.59 -0.08 -0.34% -21.65%
IQVIA Holdings Inc 241.86 -0.14 -0.06% -2.53%
McKesson 361.09 2.33 0.65% 81.97%
Allscripts Healthcare Solutions 17.35 0.24 1.40% 1.52%
Omnicell 109.11 -0.07 -0.06% -28.53%
Steris 212.17 1.96 0.93% -3.05%
Stanley Black & Decker 98.48 0.18 0.18% -50.79%
Veeva Systems 225.23 0.58 0.26% -30.01%

Indexes Price Day Year
USND 12930 150.31 1.18% -12.77%
US2000 1996 21.11 1.07% -10.20%

Omnicell
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. Its point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility’s in-house information management systems. Its Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.